DiaMedica Therapeutics DMAC
NASDAQ DMAC
$8.27 +0.07 (+0.85%)
At close: Sep 30, 2026 · 4:00 PM EDT

DiaMedica Therapeutics (DMAC) Accounts Payables (2017 - 2026)

Updated

DiaMedica Therapeutics (DMAC) posted Accounts Payables of $2.81 million for Q2 2026, up 123.0% from $1.26 million a year earlier but down 14.6% from the prior quarter.

Analysis

DiaMedica Therapeutics (DMAC) Accounts Payables (2017 - 2026) Analysis & Trends

At the end of FY2025, DiaMedica Therapeutics' Accounts Payables came in at $1.48 million, up 56.9% from FY2024.

  • Annual Accounts Payables has increased for four consecutive years, with a five-year compound annual growth rate of 6.1% (FY2020 to FY2025).
  • In prior years, DiaMedica Therapeutics' Accounts Payables was $940,000 in FY2024 (+1.5%), $926,000 in FY2023 (+26.2%), $734,000 in FY2022 (+44.2%) and $509,000 in FY2021 (-53.7%).
  • Quarterly Accounts Payables has run from a low of $433,000 in Q1 2022 to a high of $3.29 million in Q1 2026 over five years.
  • On a year-over-year basis, Accounts Payables has increased in each of the last eight quarters, with growth averaging 72.0% over the last eight quarters.
  • The strongest year-over-year quarter for Accounts Payables in the past five years was Q1 2023, with growth of 311.1%; the weakest was Q1 2024, with a decline of 59.8%.
  • According to Business Quant data, Accounts Payables for the three prior quarters was $3.29 million (Q1 2026), $1.48 million (Q4 2025) and $1.92 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 DiaMedica Therapeutics 445.97 Mn 445.97 Mn - 2.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.81 Mn
Mar 31, 2026 3.29 Mn
Dec 31, 2025 1.48 Mn
Sep 30, 2025 1.92 Mn
Jun 30, 2025 1.26 Mn
Mar 31, 2025 1.51 Mn
Dec 31, 2024 940,000.00
Sep 30, 2024 1.17 Mn
Jun 30, 2024 759,000.00
Mar 31, 2024 716,000.00
Dec 31, 2023 926,000.00
Sep 30, 2023 863,000.00
Jun 30, 2023 856,000.00
Mar 31, 2023 1.78 Mn
Dec 31, 2022 734,000.00
Sep 30, 2022 864,000.00
Jun 30, 2022 624,000.00
Mar 31, 2022 433,000.00
Dec 31, 2021 509,000.00
Sep 30, 2021 699,000.00
API Access

DiaMedica Therapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=DMAC&period=max&api_key=YOUR_API_KEY